0001193125-19-314817.txt : 20191216 0001193125-19-314817.hdr.sgml : 20191216 20191216112702 ACCESSION NUMBER: 0001193125-19-314817 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20191216 DATE AS OF CHANGE: 20191216 EFFECTIVENESS DATE: 20191216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-10638 FILM NUMBER: 191286364 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 15-12B 1 d843502d1512b.htm 15-12B 15-12B

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number:

001-10638

333-59273

 

 

Cambrex Corporation

(Exact name of registrant as specified in its charter)

 

 

One Meadowlands Plaza

East Rutherford, NJ 07073

(201) 804-3000

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.10 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

    ☒  

Rule 12g-4(a)(2)

    ☐  

Rule 12h-3(b)(1)(i)

    ☒  

Rule 12h-3(b)(1)(ii)

    ☐  

Rule 15d-6

    ☐  

Rule 15d-22(b)

    ☐  

Approximate number of holders of record as of the certification or notice date:

Common Stock, par value $0.10 per share: 1

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Cambrex Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

CAMBREX CORPORATION    
Date: December 16, 2019     By:  

/s/ Gregory P. Sargen

      Name: Gregory P. Sargen
     

Title: Chief Financial Officer, Executive Vice President Corporate Development & Strategy